BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain

J Neurosci. 2000 Jan 15;20(2):771-82. doi: 10.1523/JNEUROSCI.20-02-00771.2000.

Abstract

Brain-derived neurotrophic factor (BDNF) has trophic effects on serotonergic (5-HT) neurons in the adult brain and can prevent the severe loss of cortical 5-HT axons caused by the neurotoxin p-chloroamphetamine (PCA). However, it has not been determined whether BDNF promotes the survival of 5-HT axons during PCA-insult or facilitates their regenerative sprouting after injury. We show here that BDNF fails to protect most 5-HT axons from PCA-induced degeneration. Instead, chronic BDNF infusions markedly stimulate the sprouting of both intact and PCA-lesioned 5-HT axons, leading to a hyperinnervation at the neocortical infusion site. BDNF treatment promoted the regrowth of 5-HT axons when initiated up to a month after PCA administration. The sprouted axons persisted in cortex for at least 5 weeks after terminating exogenous BDNF delivery. BDNF also encouraged the regrowth of the 5-HT plexus in the hippocampus, but only in those lamina where 5-HT axons normally ramify. In addition, intracortical BDNF infusions induced a sustained local activation of the TrkB receptor. The dose-response profiles for BDNF to stimulate 5-HT sprouting and Trk signaling were remarkably similar, suggesting a physiological link between the two events; both responses were maximal at intermediate doses of BDNF but declined at higher doses ("inverted-U-shaped" dose-response curves). Underlying the downregulation of the Trk signal with excessive BDNF was a decline in full-length TrkB protein, but not truncated TrkB protein or TrkB mRNA levels. Thus, BDNF-TrkB signaling does not protect 5-HT neurons from axonal injury, but has a fundamental role in promoting the structural plasticity of these neurons in the adult brain.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Axons / drug effects
  • Axons / pathology
  • Axons / physiology*
  • Brain-Derived Neurotrophic Factor / administration & dosage
  • Brain-Derived Neurotrophic Factor / pharmacology*
  • Cell Survival / drug effects
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / pathology
  • Cerebral Cortex / physiology
  • Functional Laterality
  • Gene Expression Regulation / drug effects
  • Humans
  • Infusions, Parenteral
  • Male
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology*
  • Neurotoxins / toxicity
  • RNA, Messenger / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, trkA / genetics
  • Receptor, trkA / metabolism
  • Receptor, trkB / genetics
  • Receptor, trkB / metabolism
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Serotonin / physiology*
  • Time Factors
  • Transcription, Genetic / drug effects
  • p-Chloroamphetamine / toxicity*

Substances

  • Brain-Derived Neurotrophic Factor
  • Neurotoxins
  • RNA, Messenger
  • Recombinant Proteins
  • Serotonin
  • p-Chloroamphetamine
  • Receptor, trkA
  • Receptor, trkB